Leads for COVID-19 Prognosis and Therapy from Nasal Swabs

15 Nov 2021 under Highlights

A recent study, led by Shashank Tripathi from the Centre for Infectious Diseases Research, reports two novel findings: a specific gene signature in nasal swabs which can predict COVID-19 severity, and the potential offered by an FDA-approved drug (Auranofin) for COVID-19 therapy. In the study, the researchers analysed COVID-19 data from nasopharyngeal samples and were […]

---